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using "head pin" device. Swinging of the pin like a swinging of 
the pendulum was used for identifying the contact of pin 
with ionization chamber surface. It helps to avoid specific 
challenges of other technical decisions for source-to-
ionization chamber distance setting. For pin swinging the 
water tank should be mounted on to wheeled stand. Final 
mechanical uncertainty for distance we estimate as ±0.15 
mm, which correspond to the inaccuracy in dose: ±0.8 %. 
GammaMed Plus remote afterloader with source Ir-192 HDR 
(diam. 0.9 mm) was used. Varian BrachyVision V10(TG-43) 




Figure: 1 – Ionization chamber; 2 - "Head pin" positioning 
device; 3 –Holder; 4 – Mould probe. 
 
Results: Ionization chamber calibration factor ND,w 
=3.042·108 Gy/C. Beam quality factor for Ir-192 kQ =0.994 
was found by interpolation. Decay factor is 1.76. Reading: 
787 pC/min. Correction kT,P =1.022. Result for dose rate: 
0.428 Gy/min. Source-to-chamber distance is 42.02 mm 
(summation of: 39.54 mm - positioning device length; 0.05 
mm – device correction; 3.43 mm - chamber radius; -1.0 mm 
source-to-catheter upper surface distance; 0.05 mm - 
chamber dimentional correction). At the source-chamber 
distance 42.02 mm the TPS gives dose rate 0.434 Gy/min (or 
difference with measurements 1.4%). Taking into account 
absolute calibration of the source activity correction (-1%) by 
well-chamber, final difference reduces to 0.4%. 
 
Conclusion: Proposed simple design of radiation source 
holder with ionization chamber positioning device 
demonstrated agreement (within 1%) measured-to-TPS values 
for dose rate at the distance ~ 4 cm.  
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Purpose or Objective: This study was conducted for the 
purpose of establishing a quality assurance (QA) system for 
brachytherapy that can ensure patient-specific QA by 
enhancing dosimetric accuracy for patient therapy plan. The 
patient-specific QA is designed to measure point absorbed 
dose and 2D dose distribution for patient therapy plan 
 
Material and Methods: We fabricated a solid phantom that 
allowed for the insertion of an applicator for patient-specific 
QA and used an ion chamber and a film as measuring devices. 
The patient treatment plan were exported to the QA dose 
calculation software, which calculated the time weight of 
dwell position stored in the plan DICOM(Digital Imaging and 
Communications in Medicine) file to obtain an overall beam 
quality correction factor and apply this correction to dose 
calculations. Experiments were conducted after importing 
the patient treatment planning source data for the fabricated 
phantom and inserting the applicator, ion chamber, and film 
into the phantom. On completion of dose delivery, the doses 
to the ion chamber and film were checked against the 
corresponding treatment plan to evaluate the dosimetric 
accuracy. For experimental purposes, five treatment plans 
were randomly selected. 
 
Results: The beam quality correction factors for ovoid and 
tandem were found to be 1.15 and 1.10–1.12, respectively. 
The beam quality correction factor in tandem fluctuated by 
approximately 2%, depending on changes in the dwell 
position. Doses measured using the ion chamber showed 
differences ranging from -2.4% to 0.6%, as compared to the 
planned doses. As for the film, the passing rate was 90% or 
higher when assessed using the gamma value of local dose 
difference at 3% and Distance to agreement at 3 mm. 
 
Conclusion: This study intended to establish a QA system for 
the purpose of enhancing the dosimetric accuracy of 
treatment planning for high-dose-rate brachytherapy. 
Experiments and assessments related to patient-specific QA 
were implemented as planned. As a result, the self-
fabricated phantom was found to be suitable for QA in 
clinical settings. The proposed patient-specific QA for 
treatment planning is expected to contribute to reducing 
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Purpose or Objective: In Poland, there are 32 centres 
performing brachytherapy, which treated 10948 patients in 
2014. In total, all these centres use about 50 HDR machines 
with Ir-192 sources. Each source has to be replaced every 
three months, and the new sources have to be calibrated. In 
every centre this is done by measuring the source output with 
a well ionization chamber. Each centre has at least one such 
chamber which in turn has to be calibrated against the 
secondary standard. The Polish Secondary Standard 
Dosimetry Laboratory offers such calibrations for which it is 
accredited by the Polish Centre for Accreditation. The SSDL 
in Warsaw is the only laboratory in Poland and in central and 
eastern Europe performing calibration of such type of 
chambers. The service started in 2012 and since then 36 
calibrations have been performed. In this presentation the 
calibration results are analyzed. 
 
Material and Methods: The calibration procedure for well 
chambers was established at the SSDL in 2012. As a secondary 
standard, a PTW well chamber type TW33004 has been used.. 
At the Polish SSDL, the extended uncertainty of the 
calibration coefficient for user's chambers is 2.8% (k=2). The 
calibrations are performed using the Ir-192 source of the 
MicroSelectron HDR unit. Until May 2015 the SSDL calibrated 
30 well chambers from the following manufacturers: 
